Quick Answer
Sonoma Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $5.37 million for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed an increase of +71.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Sonoma Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 14.1%.
- Historical annual values: Fiscal year 2025: $5.37 million | Fiscal year 2024: $3.13 million | Fiscal year 2023: $3.82 million | Fiscal year 2022: $7.40 million | Fiscal year 2021: $4.22 million | Fiscal year 2020: $3.69 million | Fiscal year 2019: $3.69 million | Fiscal year 2018: $10.07 million | Fiscal year 2017: $17.46 million | Fiscal year 2016: $7.47 million | Fiscal year 2015: $6.14 million | Fiscal year 2014: $5.48 million | Fiscal year 2013: $7.90 million | Fiscal year 2012: $3.35 million | Fiscal year 2011: $4.37 million | Fiscal year 2010: $6.26 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: